Bio Details

Christopher J. Twomey has served on our board of directors since July 2018. Since August 2013, Mr. Twomey has served as a director and Chairman of the Audit Committee of Tandem Diabetes Care, Inc., a medical device company.

Since March 2006, Mr. Twomey has served as a director and Chairman of the Audit Committee of Senomyx, Inc., a taste technologies company. From March 1990 to June 2007, Mr. Twomey served in various roles of increasing responsibility, including as Senior Vice President, Finance and Chief Financial Officer, at Biosite Incorporated, a medical diagnostics company, until it was acquired by Inverness Medical in 2007. While serving at Biosite, Mr. Twomey was responsible for the Finance, Human Resources, Facilities, and Information Systems departments. From October 1981 to March 1990, Mr. Twomey served as an audit manager for Ernst & Young, LLP. Mr. Twomey also served as a director and Chairman of the Audit Committee of Cadence Pharmaceuticals, Inc., a specialty pharmaceutical company that was acquired by Mallinckrodt plc in 2014. Mr. Twomey received his B.A. in Business Economics from the University of California at Santa Barbara.